Xiaojin Liu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Quanji Wang, Zhuowei Lei, Zihan Wang, Qian Jiang, Zhuo Zhang, Xiaojin Liu, Biao Xing, Sihan Li, Xiang Guo, Yanchao Liu, Xingbo Li, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei
PKCθ Regulates Pituitary Adenoma Bone Invasion by Activating Osteoclast in NF-κB/IL-1β-Dependent Manner. Cancers 15 (5) (2023)
Quanji Wang, Zhuowei Lei, Zihan Wang, Qian Jiang, Zhuo Zhang, Xiaojin Liu, Biao Xing, Sihan Li, Xiang Guo, Yanchao Liu, Xingbo Li, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei
PKCθ Regulates Pituitary Adenoma Bone Invasion by Activating Osteoclast in NF-κB/IL-1β-Dependent Manner. Cancers 15 (5) (2023)
Qian Jiang, Zhuowei Lei, Zihan Wang, Quanji Wang, Zhuo Zhang, Xiaojin Liu, Biao Xing, Sihan Li, Xiang Guo, Yanchao Liu, Xingbo Li, Yiwei Qi, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei
Tumor-Associated Fibroblast-Derived Exosomal circDennd1b Promotes Pituitary Adenoma Progression by Modulating the miR-145-5p/ONECUT2 Axis and Activating the MAPK Pathway. Cancers 15 (13) (2023)
Xiaojin Liu, Yimin Huang, Yiwei Qi, Shiqiang Wu, Feng Hu, Junwen Wang, Kai Shu, Huaqiu Zhang, Jörg Walter Bartsch, Christopher Nimsky, Fangyong Dong, Ting Lei
The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma. Cancers 14 (19) (2022)